Media stories about Alcentra Capital (NASDAQ:ABDC) have been trending somewhat positive on Saturday, Accern Sentiment Analysis reports. The research firm identifies negative and positive media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Alcentra Capital earned a daily sentiment score of 0.07 on Accern’s scale. Accern also assigned news coverage about the asset manager an impact score of 46.0158735719809 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
Several equities analysts have weighed in on ABDC shares. ValuEngine raised Alcentra Capital from a “hold” rating to a “buy” rating in a research report on Monday, October 2nd. UBS Group downgraded Alcentra Capital from an “outperform” rating to an “underperform” rating in a research report on Wednesday, November 8th. Rowe downgraded Alcentra Capital from an “outperform” rating to an “underperform” rating in a research report on Wednesday, November 8th. Raymond James Financial downgraded Alcentra Capital from an “outperform” rating to an “underperform” rating in a research report on Wednesday, November 8th. Finally, Keefe, Bruyette & Woods reissued a “hold” rating and set a $9.50 price target on shares of Alcentra Capital in a research report on Friday, November 10th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, one has issued a buy rating and one has given a strong buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $12.83.
Shares of Alcentra Capital (ABDC) remained flat at $$8.36 during trading hours on Friday. 73,584 shares of the company’s stock traded hands, compared to its average volume of 104,321. The firm has a market cap of $119.09, a PE ratio of -167.17 and a beta of 0.62. Alcentra Capital has a twelve month low of $7.00 and a twelve month high of $14.73.
Alcentra Capital (NASDAQ:ABDC) last announced its quarterly earnings data on Monday, November 6th. The asset manager reported $0.34 EPS for the quarter, beating the Zacks’ consensus estimate of $0.33 by $0.01. The business had revenue of $7.61 million during the quarter. Alcentra Capital had a positive return on equity of 11.32% and a negative net margin of 2.25%. sell-side analysts predict that Alcentra Capital will post 1.29 EPS for the current year.
Alcentra Capital announced that its Board of Directors has approved a share buyback plan on Monday, November 6th that allows the company to repurchase $2.50 million in shares. This repurchase authorization allows the asset manager to buy shares of its stock through open market purchases. Shares repurchase plans are usually an indication that the company’s leadership believes its shares are undervalued.
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, January 4th. Stockholders of record on Friday, December 29th were given a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 11.96%. The ex-dividend date was Thursday, December 28th. Alcentra Capital’s dividend payout ratio is currently -1,999.60%.
In other Alcentra Capital news, Director Steven H. Reiff acquired 6,900 shares of the stock in a transaction dated Monday, November 13th. The stock was acquired at an average price of $7.23 per share, with a total value of $49,887.00. Following the completion of the transaction, the director now directly owns 35,246 shares in the company, valued at $254,828.58. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Paul J. Echausse sold 10,000 shares of Alcentra Capital stock in a transaction on Thursday, November 9th. The shares were sold at an average price of $7.45, for a total value of $74,500.00. Following the completion of the sale, the director now directly owns 58,946 shares of the company’s stock, valued at approximately $439,147.70. The disclosure for this sale can be found here. In the last ninety days, insiders bought 11,730 shares of company stock valued at $83,956. Company insiders own 4.96% of the company’s stock.
TRADEMARK VIOLATION WARNING: This piece was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another website, it was copied illegally and reposted in violation of international trademark and copyright laws. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2018/01/20/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-alcentra-capital-abdc-stock-price.html.
Alcentra Capital Company Profile
Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.
Receive News & Ratings for Alcentra Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital and related companies with MarketBeat.com's FREE daily email newsletter.